Sleep and Cancer compiles novel information on the interactions between sleep and cancer. The book highlights how prevention and treatment of sleep disturbances in clinical cancer practice helps prevent the onset of tumors and their comorbidities, both short- and long-term. It analyzes how sleep disorder treatment improves the response to antitumor therapy in the long term, presenting procedures regarding cognitive-behavioral therapy of sleep disorders that are often overlooked in the oncological field. In addition, the book suggests new therapeutic approaches in oncology that are based on the knowledge of sleep mechanisms, such as chronotherapy, use of melatonin as an adjuvant in chemo- and radiotherapy, and orexinergic drugs. Suggests new therapeutic approaches to oncology based on the knowledge of sleep mechanisms - Focuses on standardized protocols regarding psychological therapy for sleep disorders, which are needed in the oncological field - Illuminates how the prevention and treatment of sleep disturbances in cancer clinical practice improves the course and quality of life of patients and their families Portrays epidemiological, economic, and public health impacts on the relationship between sleep and cancer, with prognostic and therapeutic implications Sleep and Cancer compiles novel information on interactions between sleep and cancer. Based on studies of sleep and its influence in oncology, it expands knowledge on how to improve cancer treatments, as well as prognosis and survival of cancer patients. It highlights how prevention and treatment of sleep disturbances in clinical cancer practice helps prevent the onset of tumors and their comorbidities both short- and long-term. It analyzes how sleep disorder treatment improves the response to antitumor therapy in the long term. Sleep and Cancer: A New Frontier of Precision Medicine presents procedures regarding cognitive-behavioral therapy of sleep disorders that are overlooked in the oncological field. It suggests new therapeutic approaches in oncology, based on the knowledge of sleep mechanisms, such as chronotherapy, use of melatonin as an adjuvant in chemo- and radiotherapy, and orexinergic drugs. Dr. Maria Paola Mogavero, MD is a Neurologist and Sleep Medicine specialist with extensive experience in sleep research. She currently serves as a Neurology Researcher at the "Vita-Salute" San Raffaele University Sleep Medicine Centre, IRCCS San Raffaele, Milan, Italy, where she is also pursuing a PhD. She is board-certified in Sleep Medicine, having completed a Master’s Degree (II Level) at the Alma Mater Studiorum University of Bologna. Her academic contributions include faculty roles at the World Sleep Academy (World Sleep Society), the Master II Level in Sleep Medicine at Alma Mater Studiorum University of Bologna, the Master II Level in Sleep Clinical Medicine at the University of Foggia, and the Catania High School-University of Catania. In recognition of her outstanding research, Dr. Mogavero received the Wayne Hening Young Investigator Award from the International Restless Legs Syndrome Study Group in 2022 and 2023 and the New Investigator Award from the World Sleep Society in 2023. She has authored over 80 publications in international peer-reviewed scientific journals and contributed to several book chapters. Dr. Mogavero is a frequent speaker at national and international conferences, she has also been a speaker on sleep and cancer at national events and during the World Sleep Congresses (World Sleep Society) and serves as a reviewer for numerous scientific journals. Her primary research interests lie in Neurology and Sleep Disorders, with a particular focus on sleep-related movement disorders in both children and adults, as well as a special focus on the interrelationship between sleep and cancer. Dr. Giuseppe Lanza, is Full Professor at the University of Catania (Italy). After graduation with honors in Medicine, he trained at the School of Neurology and got the international PhD at the same University. He further trained at the Department of Neuroscience and the Department of Clinical Neurophysiology of the Newcastle University (UK) as a Clinical Research Fellow. At the same Institution, in 2013 he was selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS). From 2013, he works as Consultant Neurologist and Clinical Researcher at the Oasi Research Institute–IRCCS in Troina (Italy), which is a WHO Collaborating Center, and where he currently holds the position of Head of the Clinical Neurophysiology Research Unit. More recently, he obtained the Master of Science in Clinical Research and the international “Elio Lugaresi award for Education” by the World Sleep Society for his research in Sleep Medicine. To date, he published 178 scientific papers and the Scopus h-index is 43, along with ~4,000 citations. The primary research interest includes the translational research in Clinical Neuro